We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOX icon
201
Box
BOX
$4.6B
– –
-3,950
Closed -$65K
BP icon
202
BP
BP
$107B
– –
-2,634
Closed -$100K
BPMC
203
DELISTED
Blueprint Medicines
BPMC
– –
-96
Closed -$7K
BPT
204
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
– –
-100
Closed -$1K
BSV icon
205
Vanguard Short-Term Bond ETF
BSV
$44.6B
– –
-180
Closed -$15K
BSX icon
206
Boston Scientific
BSX
$71.5B
– –
-1,998
Closed -$81K
BTI icon
207
British American Tobacco
BTI
$128B
– –
-1,617
Closed -$60K
BUD icon
208
AB InBev
BUD
$165B
– –
-32
Closed -$3K
CAF
209
Morgan Stanley China A Share Fund
CAF
$327M
– –
-75
Closed -$2K
CAG icon
210
Conagra Brands
CAG
$7.23B
– –
-610
Closed -$19K
CARG icon
211
CarGurus
CARG
$3.47B
– –
-218
Closed -$7K
CAT icon
212
Caterpillar
CAT
$387B
– –
-82
Closed -$10K
CB icon
213
Chubb
CB
$135B
– –
-725
Closed -$117K
CBRL icon
214
Cracker Barrel
CBRL
$1.29B
– –
-73
Closed -$12K
CC icon
215
Chemours
CC
$2.37B
– –
-70
Closed -$1K
CCI icon
216
Crown Castle
CCI
$32.2B
– –
-550
Closed -$76K
CCJ icon
217
Cameco
CCJ
$42.4B
– –
-400
Closed -$4K
CCL icon
218
Carnival Corporation Ltd
CCL
$39.7B
– –
-100
Closed -$4K
CDLX icon
219
Cardlytics
CDLX
$21.5M
– –
-10
Closed -$3K
CDNA icon
220
CareDx
CDNA
$2.42B
– –
-622
Closed -$14K
CDP icon
221
COPT Defense Properties
CDP
$4.21B
– –
-250
Closed -$7K
CGC
222
Canopy Growth
CGC
$410M
– –
-607
Closed -$139K
CGNX icon
223
Cognex
CGNX
$11.3B
– –
-543
Closed -$27K
CHTR icon
224
Charter Communications
CHTR
$18.2B
– –
-196
Closed -$81K
CI icon
225
Cigna
CI
$74.6B
– –
-125
Closed -$19K
7 8
9
10 11

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.